Saving changes...

Done

Error

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

Aimee M. Banks, PharmD, BCPS,  M. Markley, PharmD, BCPS, Susan Allen, PharmD; Aimee Banks, PharmD; J
Aimee M. Banks, PharmD, BCPS, M. Markley, PharmD, BCPS, Susan Allen, PharmD; Aimee Banks, PharmD; J
on behalf of ProCE Inc.

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 08 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 170938

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately 10,000 new cases reported every year. As a chronic and progressive neurologic disease that requires lifelong, dynamic treatment via costly, high-touch medications that also require special handling and storage, multiple sclerosis therapies are often delivered via specialty pharmacy programs.The NASP/CSPE MS Core Curriculum Series is intended to increase specialty clinicians’ knowledge of the evolving MS treatment paradigm and provide the necessary professional education to counsel patients and caregivers on the myriad therapeutic options, routes of administration, and behavioral/clinical/financial variables that must be considered alongside drug therapy choices when treating MS across care settings. As the second installment in the four-module NASP/CSPE MS Core Curriculum Series, this activity provides an in-depth discussion of the various therapies used in the treatment of MS.

Objectives

Objectives
Learning Objectives:The target audience for this activity includes pharmacists and nurses caring for MS patients. Upon completion of this activity, participants will be able to:Differentiate the “platform” Disease-Modifying Therapies (DMTs) and newer oral and injectable Multiple Sclerosis (MS) therapies with regard to efficacy, safety and tolerability, and immunological activity.Recognize how the product is supplied and how to properly administer as well as store each disease-modifying therapy.Outline the latest evidence-based therapeutic regimens for relapsing MS, including staging, sequencing, and combination treatment across care settings.
Aimee M. Banks, PharmD, BCPS,  M. Markley, PharmD, BCPS, Susan Allen, PharmD; Aimee Banks, PharmD; J

Author Information Play Video Bio

Aimee M. Banks, PharmD, BCPS, M. Markley, PharmD, BCPS, Susan Allen, PharmD; Aimee Banks, PharmD; J
on behalf of ProCE Inc.

Aimee M. Banks, PharmD, BCPS Clinical Pharmacist Vanderbilt University Medical Center Multiple Sclerosis Clinic Nashville, TennesseeBrandon M. Markley, PharmD, BCPS Clinical Pharmacist Vanderbilt University Medical Center Multiple Sclerosis Clinic Nashville, TenneseeSteering/Review CommitteeSusan Allen, PharmD; Aimee Banks, PharmD; Joy Derwenskus, DO, MS; Stephanie LaPointe, PharmD; Brandon Markley, PharmD; Mel Nelson, PharmD; Stacey Ness, PharmD; Libin Philip, PharmD.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0221-9999-16-336-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error